home / lobbying

lobbying_activities

Individual lobbying activities reported in quarterly filings. Each row is one issue area for one client — includes the specific issues lobbied on, government entities contacted, and income/expense amounts.

Data license: Public Domain (U.S. Government data) · Data source: Federal Register API & Regulations.gov API

250 rows where filing_period = "second_quarter", filing_year = 2008 and issue_code = "PHA" sorted by filing_year descending

✎ View and edit SQL

This data as json, CSV (advanced)

Suggested facets: filing_type, income_amount, is_termination, received_date (date)

issue_code 1

  • PHA · 250 ✖

filing_year 1

  • 2008 · 250 ✖

filing_period 1

  • second_quarter · 250 ✖
id filing_uuid filing_type registrant_name registrant_id client_name filing_year ▲ filing_period issue_code specific_issues government_entities income_amount expense_amount is_no_activity is_termination received_date
584243 FGS GLOBAL (US) LLC (FKA FGH HOLDINGS LLC) f18cb41d-e309-4dd7-8753-77af83ceb53f Q2 FGS GLOBAL (US) LLC (FKA FGH HOLDINGS LLC) 86196 PHARMACEUTICAL CARE MANAGEMENT ASSOCIATION (PCMA) 2008 second_quarter PHA Monitor legislative developments in health care HOUSE OF REPRESENTATIVES,SENATE 60000   0 0 2008-03-23T11:31:28-04:00
621019 MAYBERRY & ASSOCIATES, LLC 2a796c06-6cc8-4bee-a132-519bdfc43ac8 Q2 MAYBERRY & ASSOCIATES, LLC 51968 PHARMACEUTICAL PRINTED LITERATURE ASSOCIATION 2008 second_quarter PHA Food, Drug and Cosmetic Act Food & Drug Administration (FDA),HOUSE OF REPRESENTATIVES,SENATE     0 0 2008-06-20T14:20:05-04:00
621023 MAYBERRY & ASSOCIATES, LLC 067e30e2-44a0-43a2-adf8-3e2a0b9c02db Q2 MAYBERRY & ASSOCIATES, LLC 51968 HEALTHCARE COMPLIANCE PACKAGING COUNCIL 2008 second_quarter PHA Pharmaceutical regimen compliance. Food & Drug Administration (FDA),HOUSE OF REPRESENTATIVES,SENATE     0 0 2008-06-20T14:35:07-04:00
621120 ABELL, HENRY & ASSOCIATES, LLC 2dd8d757-e570-4f1e-a6d6-a0ce6f4a651a Q2 ABELL, HENRY & ASSOCIATES, LLC 318378 EXPRESS SCRIPTS INCORPORATED 2008 second_quarter PHA DoD TRICARE Pharmacy Program Defense, Dept of (DOD)     0 0 2008-06-26T12:17:58-04:00
621338 DUTKO WORLDWIDE, LLC d3956d50-c96d-4bba-80a3-ad849fa7d48f Q2 DUTKO WORLDWIDE, LLC 12868 IBIS BIOSCIENCES 2008 second_quarter PHA Counsel and advise client regarding attempts to secure federal procurement contracts for biosensor device. Agriculture, Dept of (USDA),HOUSE OF REPRESENTATIVES,SENATE,Veterans Affairs, Dept of (VA) 10000   0 0 2008-07-01T09:50:05-04:00
621352 DUTKO WORLDWIDE, LLC 5fb65109-c0e5-4ae9-b96f-dd08fe786ff9 Q2 DUTKO WORLDWIDE, LLC 12868 NEWAYS INTERNATIONAL 2008 second_quarter PHA Monitor legislation pertaining to dietary supplements and pharmaceuticals, particularly S. 762 Executive Office of the President (EOP),HOUSE OF REPRESENTATIVES,SENATE 30000   0 0 2008-07-01T10:13:10-04:00
621594 CYBER SECURITY RESEARCH CONSULTANTS, LLC 6bc76ac6-dca7-45dd-837d-d367a4acc7e2 Q2 CYBER SECURITY RESEARCH CONSULTANTS, LLC 91694 PDFRAZER CONSULTING INC CANADIAN INTERNATIONAL PHARMACY ASSOCIATION 2008 second_quarter PHA Monitoring Dorgan/Snowe drug re-importation from Canada HOUSE OF REPRESENTATIVES,SENATE 14000   0 0 2008-07-01T15:45:26-04:00
621623 INDEPENDENT PHARMACY COOPERATIVE dd6c5e08-8d25-4861-abdd-4f4da3d3b8e2 Q2 INDEPENDENT PHARMACY COOPERATIVE 313098 INDEPENDENT PHARMACY COOPERATIVE 2008 second_quarter PHA S.1954 Requiring Medicare Prompt Payment of Claims, S.1951 AMP Fix legislation, H.R. 6331 Medicare Package, S. 1301 Medicare Package, H.R. 5839 directs the HHS Secretary to promulgate regulations to establish a drug identification and tracking system. H.R. 971 (Community Pharmacy Fairness Act) Allowing pharmacy negotiations with payers. Centers For Medicare and Medicaid Services (CMS),HOUSE OF REPRESENTATIVES,SENATE   10000 0 0 2008-07-01T16:37:37-04:00
621774 DUTKO WORLDWIDE, LLC e95481b2-cf36-44f6-971a-7fc8392d191b Q2 DUTKO WORLDWIDE, LLC 12868 MEDIMPACT HEALTHCARE SYSTEMS 2008 second_quarter PHA Work with CMS on the role of PBM's in delivering the Medicare Part D benefit and related operational issues. Monitored a decision by CMS and POE and reporting for MedImpact. Executive Office of the President (EOP),Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,SENATE 50000   0 0 2008-07-02T13:48:23-04:00
621898 HOSPITAL SERVICE ASSOCIATION OF NORTHEASTERN PENNSYLVANIA b21d60b5-05fa-4d96-84dc-b4c1be58af70 Q2 HOSPITAL SERVICE ASSOCIATION OF NORTHEASTERN PENNSYLVANIA 18683 HOSPITAL SERVICE ASSOCIATION OF NORTHEASTERN PENNSYLVANIA 2008 second_quarter PHA E-prescribing HOUSE OF REPRESENTATIVES,SENATE     0 0 2008-07-03T09:31:11-04:00
622114 MARSHALL BRACHMAN 055e6c1f-3ee2-4731-bd92-ad8612b00c4c Q2 MARSHALL BRACHMAN 6848 STEWART JACKSON PHARMACAL 2008 second_quarter PHA Senate HELP Committee and House Energy and Commerce Committee: monitor FDA legislation related to regulation of pharmaceutical manufacturing HOUSE OF REPRESENTATIVES,SENATE 6000   0 0 2008-07-04T15:04:24-04:00
622474 INTERNATIONAL COMMERCE DEVELOPMENT CORP fe431c33-4dc1-4965-adf2-2a6b547f4e11 Q2 INTERNATIONAL COMMERCE DEVELOPMENT CORP 286278 AMPHASTAR PHARMACEUTICALS INC 2008 second_quarter PHA Seeking generic pharmaceuticals approvals for client from the FDA and EPA. Environmental Protection Agency (EPA),Food & Drug Administration (FDA),HOUSE OF REPRESENTATIVES,SENATE 30000   0 0 2008-07-07T16:38:10-04:00
623191 RUBICON ADVISORS, LLC 96647467-0665-43a6-bdb9-d6518756be2c Q2 RUBICON ADVISORS, LLC 315091 AMERICAN SOCIETY OF INTERVENTIONAL PAIN PHYSICIANS 2008 second_quarter PHA Healthcare: centers for Medicare & Medicaid Services (CMS), Reimbursements   30000   0 0 2008-07-08T19:14:32-04:00
623192 RUBICON ADVISORS, LLC d8f68837-8c31-4c5f-bde7-148344558216 Q2 RUBICON ADVISORS, LLC 315091 FLEMING PHARMACEUTICALS 2008 second_quarter PHA Healthcare: Pharmaceuticals, Bioshield   30000   0 0 2008-07-08T19:20:33-04:00
623193 RUBICON ADVISORS, LLC cf5e02aa-f8b4-4287-9cf3-8573d3eed6ab Q2 RUBICON ADVISORS, LLC 315091 GILEAD SCIENCES 2008 second_quarter PHA Healthcare: Pharmaceuticals   75000   0 0 2008-07-08T19:25:34-04:00
623194 RUBICON ADVISORS, LLC ce7df2df-3afc-4bca-9fdc-3f8fae53e812 Q2 RUBICON ADVISORS, LLC 315091 TEVA PHARMACEUTICALS USA 2008 second_quarter PHA Healthcare: Pharmaceuticals, Prescription Drug User Fee   90000   0 0 2008-07-08T19:35:35-04:00
623195 RUBICON ADVISORS, LLC 72439a44-00a6-43e7-81f9-5b12ccb44260 Q2 RUBICON ADVISORS, LLC 315091 WATSON PHARMACEUTICALS INC 2008 second_quarter PHA Healthcare: Pharmaceuticals, Prescription Drug User Fee   102000   0 0 2008-07-08T19:40:36-04:00
623196 RUBICON ADVISORS, LLC 7f14eafe-dd9a-48cf-99d0-0cb00f3355f7 Q2 RUBICON ADVISORS, LLC 315091 INSMED INCORPORATED 2008 second_quarter PHA Pharmaceutical Issues   22500   0 0 2008-07-08T19:44:37-04:00
623301 CAPITOL HILL CONSULTING GROUP 31d342a3-8abc-4df0-b964-c44332f2fa35 Q2 CAPITOL HILL CONSULTING GROUP 72053 ASTELLAS PHARMA US 2008 second_quarter PHA Pharmaceutical and life sciences, including but not limited to: The Federal Food, Drug and Cosmetic Act; the Hatch-Waxman Act; drug importation; and drug safety HOUSE OF REPRESENTATIVES,SENATE 30000   0 0 2008-07-09T10:37:18-04:00
623345 CAPITOL HILL CONSULTING GROUP 3bb3b09c-7cff-4291-9fe7-7079a38fc797 Q2 CAPITOL HILL CONSULTING GROUP 72053 DFB PHARMACEUTICALS INC 2008 second_quarter PHA General Pharmaceutical issues pertaining to the company HOUSE OF REPRESENTATIVES,SENATE 30000   0 0 2008-07-09T10:49:28-04:00
623354 CAPITOL HILL CONSULTING GROUP 29063c95-802c-4309-8fc6-96b3769330ed Q2 CAPITOL HILL CONSULTING GROUP 72053 ELI LILLY AND COMPANY 2008 second_quarter PHA General Pharmaceutical issues pertaining to Eli Lilly and Company, including but not limited to: The Federal Food, Drug and Cosmetic Act; the Hatch-Waxman Act; and drug importation HOUSE OF REPRESENTATIVES,SENATE 20000   0 0 2008-07-09T10:51:32-04:00
623420 CAPITOL HILL CONSULTING GROUP edc0d6ea-a086-4fb9-997b-930437d02d57 Q2 CAPITOL HILL CONSULTING GROUP 72053 PHRMA 2008 second_quarter PHA General pharmaceutical issues, including but not limited to: The Federal Food and Drug and Cosmetic Act; the Hatch-Waxman Act; patent reform; drug importation; and drug safety HOUSE OF REPRESENTATIVES,SENATE 40000   0 0 2008-07-09T11:15:55-04:00
623427 CAPITOL HILL CONSULTING GROUP 4fcd4d93-c2af-4e1a-8df9-b3181127946f Q2 CAPITOL HILL CONSULTING GROUP 72053 PURDUE PHARMA LLP 2008 second_quarter PHA General Pharmaceutical issues, including but not limited to: The Federal Food, Drug, and Cosmetic Act; The Controlled Drug Substances Act; Drug Imporation; and Drug Safety HOUSE OF REPRESENTATIVES,SENATE 20000   0 0 2008-07-09T11:16:57-04:00
623649 OREGON HEALTH & SCIENCE UNIVERSITY 3cc59731-21bc-408f-92de-35d04af35478 Q2 OREGON HEALTH & SCIENCE UNIVERSITY 30291 OREGON HEALTH & SCIENCE UNIVERSITY 2008 second_quarter PHA Discounted Drug Prices for 340B Hospitals: Section 340B of the Public Health Services Act (HR 2606/S 1376). Centers For Medicare and Medicaid Services (CMS),Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,Natl Institutes of Health (NIH),SENATE   41000 0 0 2008-07-09T13:37:37-04:00
624037 CAPITOL HILL CONSULTING GROUP fc0adaa1-3fb1-4640-826b-0693d0552444 Q2 CAPITOL HILL CONSULTING GROUP 72053 NOVARTIS CORPORATION 2008 second_quarter PHA Pharmaceutical and Life Sciences issues, including but not limited to: The Federal Food, Drug and Cosmetic Act; The Hatch-Waxman Act; drug safety HOUSE OF REPRESENTATIVES,SENATE 50000   0 0 2008-07-09T16:07:25-04:00
624211 AMERICAN CAPITOL GROUP 534b1c2b-f639-45b9-aa65-1f652144c461 Q2 AMERICAN CAPITOL GROUP 305852 DISPENSING SOLUTIONS INC 2008 second_quarter PHA Drug Improtation, Pharmacy, Counterfiet Drugs, HR 5839, The Safeguarding American's Pharmaceuticals Act HOUSE OF REPRESENTATIVES,SENATE 10000   0 0 2008-07-09T17:07:15-04:00
624557 LIBERTY SQUARE DC, LLC 6880fd5b-b708-4dfb-b928-874c65b45cb4 2T LIBERTY SQUARE DC, LLC 87335 AVENUE SOLUTIONS 2008 second_quarter PHA Prompt Pay for Pharmacists - insuring pharmacists receive payment in a timely manner HOUSE OF REPRESENTATIVES,SENATE 75000   0 1 2008-07-10T11:12:59-04:00
624850 PRICEWATERHOUSECOOPERS 141d2a4a-26ac-4365-85a3-99c3a43cc405 Q2 PRICEWATERHOUSECOOPERS 10764 SCHERING-PLOUGH CORPORATION 2008 second_quarter PHA General issues affecting pharmaceutical companies Food & Drug Administration (FDA),HOUSE OF REPRESENTATIVES,SENATE 80000   0 0 2008-07-10T13:55:15-04:00
624886 HEALTHCARE DISTRIBUTION ALLIANCE(HDA)(FORMERLY HEALTHCARE DISTRIBUTION MANAGEMENT ASSOCIATION (HDMA) b25dc2dc-1d08-42c9-aea3-aa8baa865e4a Q2 HEALTHCARE DISTRIBUTION ALLIANCE(HDA)(FORMERLY HEALTHCARE DISTRIBUTION MANAGEMENT ASSOCIATION (HDMA) 28776 HEALTHCARE DISTRIBUTION ALLIANCE (FORMERLY - HDMA) 2008 second_quarter PHA Importation of prescription drugs (H.R. 3161) (S. 1644) Rx Pedigree (H.R. 5839) Methamphetamine/Pseudoephedrine Regulation (S. 2071) Internet Pharmacy (S. 980) (H.R. 6353) Food & Drug Administration (FDA),HOUSE OF REPRESENTATIVES,SENATE   235000 0 0 2008-07-10T14:23:29-04:00
625034 HEALTHCARE DISTRIBUTION ALLIANCE(HDA)(FORMERLY HEALTHCARE DISTRIBUTION MANAGEMENT ASSOCIATION (HDMA) 7487c545-12fd-4bf6-8655-dea4a598641a 2A HEALTHCARE DISTRIBUTION ALLIANCE(HDA)(FORMERLY HEALTHCARE DISTRIBUTION MANAGEMENT ASSOCIATION (HDMA) 28776 HEALTHCARE DISTRIBUTION ALLIANCE (FORMERLY - HDMA) 2008 second_quarter PHA Importation of prescription drugs (H.R. 3161) (S. 1644) Rx Pedigree (H.R. 5839) Methamphetamine/Pseudoephedrine Regulation (S. 2071) Internet Pharmacy (S. 980) (H.R. 6353) Food & Drug Administration (FDA),HOUSE OF REPRESENTATIVES,SENATE   235000 0 0 2008-07-10T15:16:25-04:00
625162 POLICY ADVOCATES 2d54c3ae-78d2-47aa-9c63-793b4a1eac24 Q2 POLICY ADVOCATES 72018 PHOENIX CAPITAL MANAGEMENT LLC 2008 second_quarter PHA S.980: Online Pharmacy Consumer Protection Act of 2007 - Track and monitor. S.596: Safe Internet Pharmacy Act of 2007 - Track and monitor. S.554: Act For Our Kids - Track and monitor. HR 380: Pharmaceutical Market Access and Drug Safety Act of 2007 - Track and monitor. S. 242: Pharmaceutical Market Access and Drug Safety Act of 2007 - Track and monitor. HOUSE OF REPRESENTATIVES,SENATE 15000   0 0 2008-07-10T16:12:53-04:00
625411 MATTOON & ASSOCIATES, LLC 8bf95052-e22a-4ea2-a9ba-8389f5e5f911 Q2 MATTOON & ASSOCIATES, LLC 314215 PHARMACEUTICAL RESEARCH AND MANUFACTURERS OF AMERICA 2008 second_quarter PHA S2029 Physician Payments Sunshine Act - all provisions HR 3610 Food and Drug Import Safety - provisions related to prescription drugs HOUSE OF REPRESENTATIVES,SENATE 90000   0 0 2008-07-11T09:24:33-04:00
625854 CARDENAS PARTNERS, LLC bb81c05c-7efe-4943-92fc-0769ad3082c0 Q2 CARDENAS PARTNERS, LLC 284573 SCHERING CORPORATION 2008 second_quarter PHA Seeking US Embassy support for American sales of pharmaceuticals in Latin America Drug Enforcement Administration (DEA),Office of Natl Drug Control Policy (NDCP),State, Dept of (DOS) 30000   0 0 2008-07-11T14:17:43-04:00
625982 APOTEX CORP. 8bcbfe73-ddf2-4ccf-814b-dd6f85f732d8 Q2 APOTEX CORP. 310973 APOTEX CORP. 2008 second_quarter PHA S 316, the Preserve Access to Affordable Generics Act HR 1902, the Protecting Consumer Access to Generic Drugs Act HR 1038, the Access to Life Saving Medicine Act HR 5629, the Pathway for Biosimilars Act S 1695, the Biologics Price Competition and Innovation Act HR 5839, the Safeguarding America's Pharmaceuticals Act HR 3610, the Food and Drug Import Safety Act, Section 4, User Fees Regarding Drug Safety Draft Senate food and drug import safety legislation PL 110-85, the Food and Drug Amendments Act of 2007, Section 914, Citizen Petitions and petitions for stay of agency action Combating anti-generic subsitution legislation in the states HOUSE OF REPRESENTATIVES,SENATE   130000 0 0 2008-07-11T15:41:41-04:00
626300 CGCN GROUP, LLC 2862d8f0-a47a-4d40-a635-0f92b51678f2 Q2 CGCN GROUP, LLC 76992 BARR PHARMACEUTICALS INC (FORMERLY BARR LABORATORIES INC ) 2008 second_quarter PHA H.R.3161, S.1859, Funding for the Office of Generic Drugs, Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act H.R.2900, S.1082, Food and Drug Administration Reform HOUSE OF REPRESENTATIVES,SENATE 30000   0 0 2008-07-13T15:41:40-04:00
626617 BROYDRICK & ASSOCIATES 7819cb68-1aed-4c8f-9a15-81bdc0a37ce9 Q2 BROYDRICK & ASSOCIATES 7268 BARR LABORATORIES 2008 second_quarter PHA Patent reform, Generic Biologies HOUSE OF REPRESENTATIVES,SENATE     0 0 2008-07-14T11:28:25-04:00
626710 APTIV, PLC 88584d20-8d4f-4663-9024-84b5f603f30a Q2 APTIV, PLC 49054 APTIV PLC 2008 second_quarter PHA Accessibility of generic drugs e-prescriptions Medical IT Commerce, Dept of (DOC),Defense Advanced Research Projects Agency (DARPA),Defense, Dept of (DOD),Energy, Dept of,Environmental Protection Agency (EPA),Federal Aviation Administration (FAA),Federal Communications Commission (FCC),Health & Human Services, Dept of (HHS),Homeland Security, Dept of (DHS),HOUSE OF REPRESENTATIVES,Intl Trade Administration (ITA),Labor, Dept of (DOL),Natl Aeronautics & Space Administration (NASA),SENATE,State, Dept of (DOS),Transportation, Dept of (DOT),Transportation Security Administration (TSA),Treasury, Dept of,White House Office   190000 0 0 2008-07-14T12:00:53-04:00
627025 GO DADDY.COM c5747029-635c-4333-83ab-9fb9dc080145 Q2 GO DADDY.COM 303553 GO DADDY COM 2008 second_quarter PHA S. 980 Controlled Substances Act HR 6353 The Ryan Haight Online Pharmacy Consumer Protection Act of 2008 Federal Communications Commission (FCC),Federal Trade Commission (FTC),HOUSE OF REPRESENTATIVES,Natl Technical Information Service,Natl Telecommunications & Information Administration (NTIA),SENATE   145000 0 0 2008-07-14T14:26:57-04:00
627968 STANTON PARK GROUP d4ca2568-dc17-4143-9969-f34e039c9c70 Q2 STANTON PARK GROUP 83717 BARR LABORATORIES 2008 second_quarter PHA Generic Biologics HR 1956; S. 1695; HR 1038; S. 623; HR 5629; FDA Reform; HOUSE OF REPRESENTATIVES,SENATE 30000   0 0 2008-07-15T10:47:21-04:00
628103 UNIVERSITY OF CONNECTICUT 1846ad2d-514a-40b2-ac01-681f6b45bd8d Q2 UNIVERSITY OF CONNECTICUT 39382 UNIVERSITY OF CONNECTICUT 2008 second_quarter PHA Implementation of Prescription Drug User Fee Amendments 2007 (Public Law 110-85), Drug safety related issues. Defense, Dept of (DOD),Food & Drug Administration (FDA),HOUSE OF REPRESENTATIVES,SENATE   70000 0 0 2008-07-15T11:15:09-04:00
628319 ASSOCIATION OF NATIONAL ADVERTISERS, INC. cc3d9acb-6b88-4113-b3ab-d4f9d07c4477 Q2 ASSOCIATION OF NATIONAL ADVERTISERS, INC. 4653 ASSOCIATION OF NATIONAL ADVERTISERS, INC. 2008 second_quarter PHA S. 2311 and H.R. 4083, Non-Prescription Drug Modernization Act of 2007, provisions to grant the FDA authority over advertising for over-the-counter drugs H.R. 6151, Responsibility in Drug and Device Advertising Act of 2008, provisions imposing a three-year moratorium on prescription drug advertising and requiring fair balance in drug advertisemetns Federal Communications Commission (FCC),Federal Trade Commission (FTC),HOUSE OF REPRESENTATIVES,SENATE   240000 0 0 2008-07-15T12:35:55-04:00
628399 THE FRITTS GROUP 9ce91e7c-bf42-475c-ae7e-6de3c5b5c63e Q2 THE FRITTS GROUP 309275 CBS 2008 second_quarter PHA H.R. 1561 - Enhancing Drug Safety and Innovation Act of 2007 HOUSE OF REPRESENTATIVES,SENATE 75000   0 0 2008-07-15T13:04:11-04:00
628408 THE FRITTS GROUP 3f68a909-78a9-4a88-a69f-9c355a5047fb Q2 THE FRITTS GROUP 309275 NEWS CORPORATION 2008 second_quarter PHA H.R. 1561 - Enhancing Drug Safety and Innovation Act of 2007 HOUSE OF REPRESENTATIVES,SENATE 75000   0 0 2008-07-15T13:07:16-04:00
628430 MENTAL HEALTH AMERICA c40d32ea-a317-4ff5-875b-1ce329938287 Q2 MENTAL HEALTH AMERICA 28195 MENTAL HEALTH AMERICA 2008 second_quarter PHA HR 6331; Improvements to Medicare prescription drug law HOUSE OF REPRESENTATIVES,SENATE,Veterans Affairs, Dept of (VA)   26103 0 0 2008-07-15T13:14:25-04:00
629032 TIMMONS AND COMPANY, INC. f6d2109f-ae47-4f6c-96cd-1845c066c10c Q2 TIMMONS AND COMPANY, INC. 38164 TEVA PHARMACEUTICALS USA INC 2008 second_quarter PHA S. 28 - To amend title XVIII of the Social Security Act to require the use of generic drugs under the Medicare part D prescription drug program when available unless the brand name drug is determined to be medically necessary. S. 1505 - Affordable Biologics for Consumers Act. S. 1695 - To amend the Public Health Service Act to establish a pathway for the licensure of biosimilar biological products, to promote innovation in the life sciences, and for other purposes. S. 242 - Pharmaceutical Market Access and Drug Safety Act of 2007. S. 251 - Pharmaceutical Market Access Act of 2007. S. 1082 - Prescription Drug User Fee Amendments of 2007. H.R. 2900 - Food and Drug Administration Amendments Act of 2007. H.R. 1956 - Patient Protection and Innovative Biologic Medicines Act. H.R. 1038 - Access to Life-Saving Medicine Act. H.R. 5629 - Pathway for Biosimilars Act H.R. 3610 - Food and Drug Import Safety Act of 2007 H.R. 3624 - Consumer Food Safety Act of 2007 HOUSE OF REPRESENTATIVES,SENATE 100000   0 0 2008-07-15T16:19:28-04:00
629087 BLUE CROSS BLUE SHIELD OF MICHIGAN a53e8fa4-eb5f-40a7-b055-4f0afad4a902 Q2 BLUE CROSS BLUE SHIELD OF MICHIGAN 46676 BLUE CROSS BLUE SHIELD OF MICHIGAN 2008 second_quarter PHA E- Prescribing; Comparative Effectiveness Research: HR 3162 " Children's Health and Medicare Protection Act of 2007"; HR 2184 "Enhanced Health Care Value for All Act" HOUSE OF REPRESENTATIVES,SENATE   30000 0 0 2008-07-15T16:39:12-04:00
629667 UPS (UNITED PARCEL SERVICE) 5846332f-315c-4e7e-8f82-4b0056ef65a8 Q2 UPS (UNITED PARCEL SERVICE) 39223 UPS (UNITED PARCEL SERVICE) 2008 second_quarter PHA Pedigree - pharmaceutical distribution Federal Aviation Administration (FAA),Food & Drug Administration (FDA),Homeland Security, Dept of (DHS),HOUSE OF REPRESENTATIVES,Labor, Dept of (DOL),SENATE,State, Dept of (DOS),Transportation, Dept of (DOT),Transportation Security Administration (TSA),U.S. Customs & Border Protection,U.S. Trade Representative (USTR)   1302504 0 0 2008-07-16T09:19:44-04:00
629699 JAMES P. KEESE ca51adf0-e4e1-4d94-8daf-84dee6969629 Q2 JAMES P. KEESE 74556 TEVA PHARMACEUTICALS USA 2008 second_quarter PHA S. 623/Access to Life-Saving Medicine Act, S. 438/Fair Prescription Drug Competition Act, H.R. 806/Fair Prescription Drug Competition Act, H.R. 1956/Patient Protection and Innovative Biologic Medicines Act of 2007, H.R. 5629, H.R. 1038/Access to Life-Saving Medicine Act, S. 1505/Affordable Biologics for Consumers Act, S. 1695/Biologics Act of 2007, HR 3610 Centers For Medicare and Medicaid Services (CMS),Federal Trade Commission (FTC),Food & Drug Administration (FDA),Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,Patent & Trademark Office (PTO),SENATE,U.S. Trade Representative (USTR) 40000   0 0 2008-07-16T09:53:54-04:00
630124 DEPARTMENT FOR PROFESSIONAL EMPLOYEES, AFL-CIO 37600d88-cd41-463c-b67c-14b9e464dc1a Q2 DEPARTMENT FOR PROFESSIONAL EMPLOYEES, AFL-CIO 12094 DEPARTMENT FOR PROFESSIONAL EMPLOYEES AFL-CIO 2008 second_quarter PHA - Support legislation to encourage biogeneric drugs HOUSE OF REPRESENTATIVES,SENATE   10000 0 0 2008-07-16T11:46:49-04:00
630524 KEVIN MCGUINESS PLLC d07fb7b8-0cc1-490f-b5ed-c7581a6b6d95 Q2 KEVIN MCGUINESS PLLC 299811 BARR LABS 2008 second_quarter PHA Issues that relate to legislation addressing the FDA, Bioshield, and generic biologics; S.623/H.R. 1032, Access to Life Saving Medicine Act HOUSE OF REPRESENTATIVES,SENATE 20000   0 0 2008-07-16T13:29:16-04:00
630600 UNIVERSITY OF PITTSBURGH MEDICAL CENTER 6ee86065-d415-4e05-963d-7a6840d79976 Q2 UNIVERSITY OF PITTSBURGH MEDICAL CENTER 32065 UNIVERSITY OF PITTSBURGH MEDICAL CENTER 2008 second_quarter PHA Issues related to the cost of prescription pharmaceuticals and the impact of that cost on hospitals and health care providers. Air Force, Dept of,Army, Dept of (Other),Centers For Medicare and Medicaid Services (CMS),Defense, Dept of (DOD),Health & Human Services, Dept of (HHS),Health Resources & Services Administration (HRSA),HOUSE OF REPRESENTATIVES,SENATE   260000 0 0 2008-07-16T13:48:37-04:00
630692 MICHAEL POLLARD dc23cbd3-8d4a-4d01-8bd1-5920f099c263 Q2 MICHAEL POLLARD 87836 MEDCO HEALTH SOLUTIONS INC 2008 second_quarter PHA HR 971 and S 885 - Community Pharmacy Fairness Act of 2007; all aspects HR 1474 - Fair and Speedy Treatment (FAST) of Medicare Prescription Drug Claims Act of 2007; all aspects HR 2970 - Pharmacy Benefit Manager Transparency Act of 2007; all aspects HR 3140 - Saving Our Community Pharmacies Act of 2007; all aspects HR 3090 - Patient and Pharmacy Protection Act of 2007; all aspects HR 3193 Access to Community Pharmacy Preservation Act of 2007; all aspects S 242 - Pharmaceutical Market Access and Drug Safety Act of 2007; all aspects S 251 - Pharmaceutical Market Access Act of 2007; all aspects S 596 - Safe Internet Pharmacy Act of 2007; section 511(c) S 980 - Online Pharmacy Consumer Protection Act of 2007; all aspects S 1954 - Pharmacy Access Improvement (PhAIm) Act of 2007; all aspects S 2161 - Community Pharmacy Fairness Act of 2007; all aspects Centers For Medicare and Medicaid Services (CMS),Federal Trade Commission (FTC),Government Accountability Office (GAO),Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,SENATE,White House Office 50000   0 0 2008-07-16T14:02:58-04:00
630729 AVENUE SOLUTIONS ad51507e-62b4-4d15-9bcd-69b98c6dbb51 Q2 AVENUE SOLUTIONS 72111 EXPRESS SCRIPTS INC 2008 second_quarter PHA Issues relating to prompt pay. HOUSE OF REPRESENTATIVES,SENATE 80000   0 0 2008-07-16T14:09:10-04:00
630744 CAPITOL HILL CONSULTING GROUP 1f9b8a4a-fefd-4cdf-ac17-3b5c44fbf01c 2A CAPITOL HILL CONSULTING GROUP 72053 ASTELLAS PHARMA US 2008 second_quarter PHA Pharmaceutical and life sciences, including but not limited to: The Federal Food, Drug and Cosmetic Act; the Hatch-Waxman Act; and drug safety HOUSE OF REPRESENTATIVES,SENATE 30000   0 0 2008-07-16T14:12:14-04:00
630753 AVENUE SOLUTIONS 566a6ea7-573a-4215-a643-bea028fe953b Q2 AVENUE SOLUTIONS 72111 UNITEDHEALTH GROUP INC 2008 second_quarter PHA Issues relating to prompt pay. HOUSE OF REPRESENTATIVES,SENATE 80000   0 0 2008-07-16T14:13:17-04:00
630770 BLANK ROME GOVERNMENT RELATIONS e8ecaace-c0b8-4e2a-a108-020312f57879 Q2 BLANK ROME GOVERNMENT RELATIONS 6325 ABBOTT LABORATORIES 2008 second_quarter PHA Issues related to hydrocodone Drug Enforcement Administration (DEA) 50000   0 0 2008-07-16T14:19:22-04:00
630900 VAN FLEET ASSOCIATES c94cfcd6-0eac-4f0f-9b9e-b4d89d735a97 Q2 VAN FLEET ASSOCIATES 39781 KIRK PHARMACEUTICALS 2008 second_quarter PHA FDA DEA regulations pertaining to over the counter drug sales. Drug Enforcement Administration (DEA),Food & Drug Administration (FDA),HOUSE OF REPRESENTATIVES,SENATE 9000   0 0 2008-07-16T14:50:00-04:00
631573 POLICY DIRECTIONS INC. 52878409-867b-4343-9189-1059a11e7aeb Q2 POLICY DIRECTIONS INC. 31747 ALPHARMA INC/PFIZER ANIMAL HEALTH (FORMERLY KNOWN AS ALPHARMA INC ) 2008 second_quarter PHA Antibiotics in animal foods Drug approvals S. 549/HR 962, all titles, to end the use of certain antibiotics in animal feed if those antibiotics are used in human medicine. S. 2313/HR3697, all titles, to require the manufacturers of antibiotics used in animal feed to make certain reports to FDA. HR 3610 to reform FDA regulation of federal imported and domestic food safety with emphasis on those titles related to the import of ingredients for food and drugs, as well as country-of-origin labeling. Monitor legislative and regulatory developments related to the Animal Drug User Fee Act reauthorization, with related developments of the Generic Animal Drug UserFee Act. Monitor developments of the Food & Drug Administrations development of its Advanced Feed Safety System related to the use of animal drugs in livestock and poultry feeds. Agriculture, Dept of (USDA),Food & Drug Administration (FDA),HOUSE OF REPRESENTATIVES,SENATE 20000   0 0 2008-07-16T17:18:28-04:00
631620 BLUE CROSS AND BLUE SHIELD OF KANSAS, INC. e3f7bada-41a4-467e-b559-e1d8feecf822 Q2 BLUE CROSS AND BLUE SHIELD OF KANSAS, INC. 323876 BLUE CROSS AND BLUE SHIELD OF KANSAS INC 2008 second_quarter PHA E-prescribing; Comparative Effectiveness Research: HR3162 "Children's Health and Medicare Protection Act of 2007" Section 904 only; HR2184 "Enhanced Health Care Value for All Act" Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,SENATE   10000 0 0 2008-07-16T17:26:42-04:00
631747 PARRY, ROMANI, DECONCINI & SYMMS 9aec6462-19f8-40b1-9eb5-cc1568a2bad5 Q2 PARRY, ROMANI, DECONCINI & SYMMS 30792 INTL ACADEMY OF COMPOUNDING PHARMACISTS 2008 second_quarter PHA Issues related to the compounding pharmacies, in particular relating to FDA action to ban the hormone estriol from compounded estrogens (see next page). Support of H. Con. Res. 342, Expressing the sense of Congress that the Food and Drug Administration's (FDA) new policy restricting women's access to medications containing estriol does not serve the public interest. (Introduced in House), and Support of S. Con. Res. 88, Support of Expressing the sense of Congress that the Food and Drug Administration's (FDA) new policy restricting women's access to medications containing estriol does not serve the public interest. (Introduced in Senate) HOUSE OF REPRESENTATIVES,SENATE 60000   0 0 2008-07-16T18:05:16-04:00
631997 VERN CLARK & ASSOCIATES, INC. 92a3057b-5742-4bc1-9894-bcfa564336ab Q2 VERN CLARK & ASSOCIATES, INC. 9421 WILMER CUTLER PICKERING HALE & DORR (ON BEHALF OF THE MEDICINES COMPANY) 2008 second_quarter PHA H.R. 6344 - Responsive Government Act of 2008 - patent issue. SENATE 20000   0 0 2008-07-16T21:02:32-04:00
632643 FLYNN & ASSOCIATES, INC. 3f01a22f-c60b-4fcf-b80b-6cc225032556 Q2 FLYNN & ASSOCIATES, INC. 15020 PHARMACEUTICAL INDUSTRY LABOR-MANAGEMENT ASSOCIATION 2008 second_quarter PHA State Children's Health Insurance Program Pharmaceutical industry employment issues Intellectual Property law reform HOUSE OF REPRESENTATIVES,SENATE 60000   0 0 2008-07-17T10:21:17-04:00
632723 VAN SCOYOC ASSOCIATES 156bf0f4-daa4-414b-90ef-bd17d4e1e26d Q2 VAN SCOYOC ASSOCIATES 39837 UNIVERSITY OF CONNECTICUT 2008 second_quarter PHA Implementation of Prescription Drug User Fee Amendments 2007 (Public Law 110-85), Drug safety related issues. Defense, Dept of (DOD),Food & Drug Administration (FDA),HOUSE OF REPRESENTATIVES,SENATE 50000   0 0 2008-07-17T10:30:43-04:00
632736 ACADEMY OF MANAGED CARE PHARMACY ae5c0103-7868-456c-a2e9-cfc0f2c40bd9 Q2 ACADEMY OF MANAGED CARE PHARMACY 48793 ACADEMY OF MANAGED CARE PHARMACY 2008 second_quarter PHA Establishing a regulatory pathway for Food and Drug Administration approval of follow-on biologic products, electronic prescribing of controlled substances, regulation of online pharmacies, importation of prescription drugs HOUSE OF REPRESENTATIVES,SENATE   45000 0 0 2008-07-17T10:31:14-04:00
632747 VAN SCOYOC ASSOCIATES 484def37-7494-469c-84ef-f23d0028c0db Q2 VAN SCOYOC ASSOCIATES 39837 UNIVERSITY OF MARYLAND BALTIMORE 2008 second_quarter PHA Implementation of Prescription Drug User Fee Amendments, 2007 (PL 110-85), Drug safety related issues. H.R. 2900, Food and Drug Administration Amendments Act of 2007, drug safety related issues. Defense, Dept of (DOD),Food & Drug Administration (FDA),Health & Human Services, Dept of (HHS),Homeland Security, Dept of (DHS),HOUSE OF REPRESENTATIVES,SENATE 30000   0 0 2008-07-17T10:31:47-04:00
632775 VAN SCOYOC ASSOCIATES 5b452f24-da1b-4380-b7a0-1947656d0c4a Q2 VAN SCOYOC ASSOCIATES 39837 UNIVERSITY OF PENNSYLVANIA SCHOOL OF MEDICINE 2008 second_quarter PHA Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act, FY2009, FDA and USDA funding initiatives. Implementation of Prescription Drug User Fee Amendments, 2007 (Public Law 110-85), Drug safety related issues. H.R. 3580, Food and Drug Administration Amendments Act of 2007, Drug safety and science related issues. Food & Drug Administration (FDA),Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,SENATE 40000   0 0 2008-07-17T10:33:56-04:00
632793 LATHAM & WATKINS LLP b64860b4-1a17-4b16-a354-6cb5050a00d9 Q2 LATHAM & WATKINS LLP 22201 AMPHASTAR PHARMACEUTICALS 2008 second_quarter PHA Congressional oversight of the Food and Drug Administration and Environmental Protection Agency EPA rulemaking on CFC propellants Environmental Protection Agency (EPA),Food & Drug Administration (FDA) 10000   0 0 2008-07-17T10:36:03-04:00
632822 LATHAM & WATKINS LLP e3c45d57-f92a-421e-b2c7-c4f04d83ad3e Q2 LATHAM & WATKINS LLP 22201 ORCHID CHEMICALS & PHARMACEUTICALS LTD 2008 second_quarter PHA Food and Drug Administration policy. Food & Drug Administration (FDA),HOUSE OF REPRESENTATIVES,SENATE 10000   0 0 2008-07-17T10:42:09-04:00
632868 AMYLIN PHARMACEUTICALS df777223-d31e-424a-ae90-fee6eaf66ddf Q2 AMYLIN PHARMACEUTICALS 308536 AMYLIN PHARMACEUTICALS 2008 second_quarter PHA H.R. 1038, Access to Life-Saving Medicine Act, follow-on biologics H.R. 1561, Enhancing Drug Safety and Innovation Act of 2007, drug safety provisions H.R. 1956, Patient Protection and Innovative Biologic Medicines Act of 2007, follow-on biologics S. 1505, Affordable Biologics for Consumers Act, follow-on biologics S. 1695, Biologics Price Competition and Innovation Act of 2007, follow-on biologics S. 2029, Physician Payments Sunshine Act of 2007 S. 596 Safe Internet Pharmacy Act of 2007, clinical trials, drug safety provisions S. 623, Access to Life-Saving Medicine Act, follow-on biologics Drug Importation H.R., Pathway for Biosimilars Act H.R. 5839, Safeguarding America's Pharmaceuticals Act of 2008 Centers For Medicare and Medicaid Services (CMS),Commerce, Dept of (DOC),Executive Office of the President (EOP),Food & Drug Administration (FDA),Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,SENATE   495000 0 0 2008-07-17T10:47:56-04:00
632922 MCDERMOTT WILL & SCHULTE LLP 5f72fba7-89f2-4b7f-a5b1-84112f5e4f20 Q2 MCDERMOTT WILL & SCHULTE LLP 24338 RURAL REFERRAL CENTER/SOLE COMMUNITY HOSPITAL COALITION 2008 second_quarter PHA Amendments to Section 340(b) of the Public Health Service Act to gain eligibility for rural referral centers and sole community hospitals in the federal discount drug purchasing program. Centers For Medicare and Medicaid Services (CMS),HOUSE OF REPRESENTATIVES,SENATE 80000   0 0 2008-07-17T10:55:06-04:00
633114 FIERCE, ISAKOWITZ & BLALOCK f63a7faa-1acd-4020-9998-416e992d31e0 Q2 FIERCE, ISAKOWITZ & BLALOCK 44812 MOMENTA PHARMACEUTICALS, INC. 2008 second_quarter PHA Generic Biologics Biologics: S.623/H.R.1038: Access to Life Saving Medicines Act Biologics: H.R.5629: Pathway for Biosimilars Act Biologics: S.1695: Biologics Price Competition and Innovation Act of 2007 Drug Safety as part of the Food and Drug Administration Globalization Act Food & Drug Administration (FDA),Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,SENATE,White House Office 20000   0 0 2008-07-17T11:16:15-04:00
633343 PARRY, ROMANI, DECONCINI & SYMMS f4f0b832-d00d-409d-ad85-fbcdfa17530a Q2 PARRY, ROMANI, DECONCINI & SYMMS 30792 SUNOVION PHARMACEUTICALS INC (FORMERLY SEPRACOR INC ) 2008 second_quarter PHA No specific legislation or bills introduced at this time. Medicare reimbursement issues. HOUSE OF REPRESENTATIVES,SENATE 60000   0 0 2008-07-17T11:58:42-04:00
633375 KIRKLAND & ELLIS LLP eff0cf37-1191-4bb2-a9ff-41761a139daf Q2 KIRKLAND & ELLIS LLP 21745 TEVA PHARMACEUTICALS USA 2008 second_quarter PHA House and Senate legislation on biologic medicines. HOUSE OF REPRESENTATIVES,SENATE 20000   0 0 2008-07-17T12:03:54-04:00
633669 NATIONAL ASSOCIATION OF CHAIN DRUG STORES 8ecde963-aee0-4260-9e44-8d1138a51834 Q2 NATIONAL ASSOCIATION OF CHAIN DRUG STORES 26672 NATIONAL ASSOCIATION OF CHAIN DRUG STORES 2008 second_quarter PHA See addendum. H.R.970, the Dextromethorphan Distribution Act, as related to the abuse of dextromethorphan. H.R.971, the Community Pharmacy Fairness Act, as related to provider negotiations in the Medicare program. H.R.1038/S.623, Access to Life-Saving Medicine Act, as related to the approval of generic biopharmaceuticals. H.R.1108, Family Smoking Prevention and Tobacco Control Act, as related to the regulation of the sale of tobacco products. H.R.1474, the Fair and Speedy Treatment (FAST) of Medicare Prescription Drug Claims Act, as related to provider reimbursement in the Medicare program. H.R.3140, Saving Our Community Pharmacies Act, as related to Medicaid provider reimbursement. H.R.3193, Access to Community Pharmacy Preservation Act, as related to Medicaid provider reimbursement. H.R.3700, the Fair Medicaid Drug Payment Act, as related to pharmacy reimbursement in the Medicaid program. H.R.4008, Credit and Debit Card Receipt Clarification Act of 2007, as related to fair credit card practices. H.R.5491, Emilys Act, as related to the certification of pharmacy technicians. H.R.5546, Credit Card Fair Fee Act of 2008, as related to fair credit card practices. H.R.5613, Protecting the Medicaid Safety Net Act of 2008, as related to provider participation in the Medicaid program. H.R.5629, Pathway for Biosimilars Act, as related to the availability of generic pharmaceuticals. H.R.5658, Duncan Hunter National Defense Authorization Act for Fiscal Year 2009, as related to provider participation in the TRICARE program. H.R.5839, Safeguarding America's Pharmaceuticals Act of 2008, as related to drug safety and electronic tracking of pharmaceuticals. H.R.6252, Medicare DMEPOS Competitive Acquisition Reform Act of 2008, as related to provider participation in the Medicare competitive bidding program. H.R.6331, the Medicare Improvements for Patients and Providers Act of 2008, as related to pharmacy reimbursement, electronic health care, and Medicare programs. H.R.6353, Ryan Haight Online Pharmacy Consumer Protection Act of … Centers For Medicare and Medicaid Services (CMS),Defense, Dept of (DOD),Drug Enforcement Administration (DEA),Executive Office of the President (EOP),Federal Trade Commission (FTC),Food & Drug Administration (FDA),Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,Justice, Dept of (DOJ),Office of Natl Drug Control Policy (NDCP),President of the U.S.,SENATE   420000 0 0 2008-07-17T13:23:38-04:00
634288 THE ACCORD GROUP 69895640-44ce-469a-8808-2305673cdeb6 Q2 THE ACCORD GROUP 42785 CIBA SPECIALTY CHEMICALS CORP 2008 second_quarter PHA Sucreen additives Commerce, Dept of (DOC),HOUSE OF REPRESENTATIVES,SENATE,U.S. International Trade Commission (ITC) 37500   0 0 2008-07-17T15:06:40-04:00
634344 THE ACCORD GROUP bcd830fe-dffd-480b-9d2b-fb2ae5e5cf81 Q2 THE ACCORD GROUP 42785 CITIZENS FOR SUN PROTECTION 2008 second_quarter PHA Final promulgation of sunscreen monograph HOUSE OF REPRESENTATIVES,SENATE     0 0 2008-07-17T15:14:00-04:00
634442 AMERICA'S ESSENTIAL HOSPITALS 6b9d6c72-d610-4c40-bd69-610c67f8ec04 Q2 AMERICA'S ESSENTIAL HOSPITALS 27057 AMERICA'S ESSENTIAL HOSPITALS 2008 second_quarter PHA H.R. 2606/S. 1376, 340B Program Improvement and Integrity Act of 2007 HOUSE OF REPRESENTATIVES,SENATE   405000 0 0 2008-07-17T15:19:24-04:00
634539 SHIRE PHARMACEUTICALS LLC acbdb320-4b44-4e0b-bb68-a5746698e751 Q2 SHIRE PHARMACEUTICALS LLC 323477 SHIRE PHARMACEUTICALS LLC 2008 second_quarter PHA Biosimilars legislation; orphan provisions; ADHD HOUSE OF REPRESENTATIVES,SENATE   120000 0 0 2008-07-17T15:30:17-04:00
634719 THE CIGNA GROUP AND SUBSIDIARIES (FORMERLY CIGNA CORPORATION AND SUBSIDIARIES) d9c0a43f-f5f6-4409-94a5-339a723dbde1 Q2 THE CIGNA GROUP AND SUBSIDIARIES (FORMERLY CIGNA CORPORATION AND SUBSIDIARIES) 9237 THE CIGNA GROUP AND SUBSIDIARIES (FORMERLY CIGNA CORPORATION AND SUBSIDIARIES) 2008 second_quarter PHA S.1505, Affordable Biologics for Consumers Act (Gregg) Issues relating to long term safety and effectiveness of medical devices and drugs. Centers For Medicare and Medicaid Services (CMS),Congressional Budget Office (CBO),Executive Office of the President (EOP),Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,SENATE,Treasury, Dept of   210000 0 0 2008-07-17T15:41:09-04:00
634773 TARPLIN, DOWNS & YOUNG, LLC 28cd3e29-6a1f-47d8-b1f0-e778a0895d5f Q2 TARPLIN, DOWNS & YOUNG, LLC 304736 HEALTHCARE DISTRIBUTION ALLIANCE (HEALTHCARE DISTRIBUTION MANAGMENT ASSN.) 2008 second_quarter PHA **see addendum page Importation of prescription drugs (H.R. 3161) (S. 1644) Rx Pedigree (H.R. 5839) Methamphetamine/Pseudoephedrine Regulation (S. 2071) Internet Pharmacy (S. 980) (H.R. 6353) Centers For Medicare and Medicaid Services (CMS),Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,SENATE,White House Office 60000   0 0 2008-07-17T15:45:30-04:00
634844 DUANE MORRIS GOVERNMENT AFFAIRS 6c7a81ca-8126-47c7-b6da-0b92aa3c2254 Q2 DUANE MORRIS GOVERNMENT AFFAIRS 49657 CB DISTRIBUTORS INC 2008 second_quarter PHA Regulation of over-the-counter asthma-cough medicines. Drug Enforcement Administration (DEA),Food & Drug Administration (FDA),HOUSE OF REPRESENTATIVES,SENATE 60000   0 0 2008-07-17T15:51:59-04:00
634887 TARPLIN, DOWNS & YOUNG, LLC d81136d9-a5b8-4697-9c4a-c978dca80c7c Q2 TARPLIN, DOWNS & YOUNG, LLC 304736 ADVAMED 2008 second_quarter PHA Import Safety H.R. 3610 Food and Drug Import Safety Act of 2007 ***no specific bills, Import Safety, Implementation of FDAAA, Preemption Centers For Medicare and Medicaid Services (CMS),Food & Drug Administration (FDA),Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,SENATE,White House Office 60000   0 0 2008-07-17T15:55:21-04:00
635257 FIERCE, ISAKOWITZ & BLALOCK 9abe67b6-8597-4d5f-9276-a42ba01408f0 Q2 FIERCE, ISAKOWITZ & BLALOCK 44812 MEDCO HEALTH SOLUTIONS INC AND ITS SUBSIDIARIES 2008 second_quarter PHA Health Information Technology S.1693: Wired for Health Care Quality Act Anti-trust H.R.971/S.2161: Community Pharmacy Fairness Act Pharmacy Reimbursement H.R.1474: Fair and Speedy Treatment of Medicare Drug Claims Act S.1954: Pharmacy Access Improvement Act of 2007 Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,SENATE,White House Office 80000   0 0 2008-07-17T16:27:41-04:00
635336 FIERCE, ISAKOWITZ & BLALOCK f1139721-1479-403b-b78d-f7af8e774ecc Q2 FIERCE, ISAKOWITZ & BLALOCK 44812 COALITION FOR A COMPETITIVE PHARMACEUTICAL MARKET 2008 second_quarter PHA Biologics S.623/H.R.1038: Access to Life Saving Medicines Act H.R.5629: Pathway for Biosimilars Act S.1695:, Biologics Price Competition and Innovation Act of 2007 State generic drug substitution laws HOUSE OF REPRESENTATIVES,Medicare Payment Advisory Commission (MedPAC),SENATE 50000   0 0 2008-07-17T16:33:18-04:00
635501 WINSTON & STRAWN LLP 30375c34-43bd-4d2c-9fd0-7d833b4b7e3c Q2 WINSTON & STRAWN LLP 41682 FRESENIUS KABI USA (FORMERLY KNOWN AS APP PHARMACEUTICALS INC ) 2008 second_quarter PHA Represent the client on issues related to assuring a safe supply of heparin. Food & Drug Administration (FDA),HOUSE OF REPRESENTATIVES,SENATE 40000   0 0 2008-07-17T16:48:24-04:00
635698 NATIONAL COMMUNITY PHARMACISTS ASSOCIATION bf0e8396-d6c5-4f4d-ae6d-402086dba718 Q2 NATIONAL COMMUNITY PHARMACISTS ASSOCIATION 27478 NATIONAL COMMUNITY PHARMACISTS ASSOCIATION 2008 second_quarter PHA I. HR 971, the "Community Pharmacy Fairness Act of 2007"; S. 2161, the "Community Pharmacy Fairness Act of 2007"; CMS-2238-P, CMS-2238-FC and CMS-2238-IFC, the proposed, final rule, and interim final rule re implementation the Medicaid provisions of the Deficit Reduction Act of 2005; CMS-1270F, Final rule implementing the competitive acquisition program requirements for Durable Medical Equipment Prosthetics, Orthotics and Supplies; HR 2900, provision related to pedigree requirements; HR 4 and S.3, the "Medicare Prescription Drug Price Negotiation Act of 2007"; potential language not included in S. 2499, the "Medicare, Medicaid and SCHIP Extension Act of 2007" re e-prescribing; HR 1474, the "Fair and Speedy Treatment (FAST) of Medicare Prescription Drug Claims Act of 2007; CMS-6006-P, proposed rule requring a surety bond for all Medicare DMEPOS providers; Sec. 913 of FDAAA of 2007, relating to development of a standard numerical drug identifier; and HR 5839, the "Safeguarding America's Pharmaceuticals Act of 2008," provisions relating to imposition of pedigree and track and trace requirements upon community pharmacy; II. and also HR 3140, "Saving Our Community Pharmacies Act of 2007"; S. 1951, the "Fair Medicaid Drug Payment Act of 2007"; S. 1954, the "Pharmacy Access Improvement (PhAIm) Act of 2007"; HR 3700, the "Fair Medicaid Drug Payment Act of 2007"; Sec. 7002(b) of HR 2006 and PL 110-28, "Requirements for Use of Tamper-Resistant Prescription Pads Under the Medicaid Program", (the U.S. Troop Readiness, Veterans' Care, Katrina Recovery, and Iraq Accountability Appropriations Act of 2007); PL 110-181 -- HR 1585, HR 4986 and S. 1547, National Defense Authorization Act for Fiscal Year 2008, provisions related to pharmacy payment - sections 703 and 702 of HR 1585 and HR 4986 and Sec. 701 of S. 1547, HR 6357, the "PRO(TECH)T Act of 2008", provisions impacting health technology requirements for pharmacies; HR 6331, the "Medicare Improvements for Patients and Prviders Act of 2008," Sec. 154 related to Medica… Centers For Medicare and Medicaid Services (CMS),Defense, Dept of (DOD),Drug Enforcement Administration (DEA),Federal Trade Commission (FTC),Food & Drug Administration (FDA),Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,SENATE,White House Office   180000 0 0 2008-07-17T17:16:24-04:00
635829 JOHNSON & JOHNSON SERVICES, INC. 7f0a37a5-d05d-4c59-ab8c-2ec249911d93 Q2 JOHNSON & JOHNSON SERVICES, INC. 20686 JOHNSON & JOHNSON SERVICES INC 2008 second_quarter PHA H.R. 2589, "Improving Pharmaceuticals for Children Act of 2007," regarding amending the Federal Food, Drug, and Cosmetics Act and the Public Health Service Act to reauthorize and amend the Best Pharmaceuticals for Children Act and the Pediatric Research Equity Act. S 1156, Best Pharmaceuticals for Children Amendments of 2007, regarding amending the Federal Food, Drug, and Cosmetic Act to reauthorize the Best Pharmaceuticals for Children program; S 242, Pharmaceutical Market Access and Drug Safety Act of 2007, regarding amending the Federal Food, Drug, and Cosmetic Act with respect to the importation of prescription drugs; S 251, Pharmaceutical Market Access Act of 2007, regarding amending the Federal Food, Drug, and Cosmetic Act with respect to the importation of prescription drugs; HR 4083 / S 2311, "Non-Prescription Drug Modernization Act of 2007," regarding amending the Federal Food, Drug, and Cosmetic Act to provide for the amendment or repeal of mongraphs, to expand the Food and Drug Administration's authority to regulate drug advertising, and for other purposes; S 1951, "Fair Medicaid Drug Payment Act of 2007," regarding amending title XIX of the Social Security Act to ensure that individuals eligible for medical assistance under the Medicaid program continue to have access to prescription drugs, and for other purposes. Centers For Medicare and Medicaid Services (CMS),HOUSE OF REPRESENTATIVES,SENATE   1700000 0 0 2008-07-17T17:45:03-04:00
636012 WINBORN SOLUTIONS LLC dd9ec45b-6419-4305-9677-22fa4b174274 Q2 WINBORN SOLUTIONS LLC 308310 PERRIGO CO 2008 second_quarter PHA Food and drug safety, user fee, and country of origin legislation Commerce, Dept of (DOC),HOUSE OF REPRESENTATIVES,SENATE 18000   0 0 2008-07-17T18:19:40-04:00
636199 WINSTON & STRAWN LLP c1bb3d0d-52bb-469f-b41e-d05ff0f00692 Q2 WINSTON & STRAWN LLP 41682 BARR LABORATORIES INC 2008 second_quarter PHA Hatch - Waxman reform HOUSE OF REPRESENTATIVES,SENATE 50000   0 0 2008-07-17T19:26:05-04:00
636284 MFJ INTERNATIONAL 321f27a6-26cc-4294-9a22-ccb67c747538 Q2 MFJ INTERNATIONAL 59331 TEVA PHARMACEUTICALS USA, INC. 2008 second_quarter PHA Trade issues and access to medicines. HOUSE OF REPRESENTATIVES,SENATE 10000   0 0 2008-07-17T21:53:20-04:00
636286 MFJ INTERNATIONAL 7806d999-3a39-4438-879f-346b59c63f69 Q2 MFJ INTERNATIONAL 59331 GENERIC PHARMACEUTICAL ASSOCIATION 2008 second_quarter PHA Trade agreements and access to medicines. HOUSE OF REPRESENTATIVES,SENATE 10000   0 0 2008-07-17T21:57:21-04:00
636612 ASSOCIATION FOR ACCESSIBLE MEDICINES 3990f65d-73b0-438a-948e-d17572ec9b51 Q2 ASSOCIATION FOR ACCESSIBLE MEDICINES 16032 ASSOCIATION FOR ACCESSIBLE MEDICINES 2008 second_quarter PHA Generic Biologics, including but not limited to: S.623, S.1505, S.1695, H.R.1038, H.R.1956, and H.R.5629 Prescription Drug Safety Food and Drug Administration Amendments Act of 2007 (H.R.3580): any parts relating to access to generic drugs and the impact and marketing of prescription drugs Citizen Petitions, including but not limited to: S.25 and S.1088 Counterfeit Drugs/Import Safety/Pedigree Electronic Prescribing (E-Prescribing) Authorized Generics including but not limited to: S.2408 and H.R.4296 Prescription Drug Importation/Re-Importation Any other matters that relates to access to generic drugs Centers For Medicare and Medicaid Services (CMS),Commerce, Dept of (DOC),Congressional Budget Office (CBO),Federal Trade Commission (FTC),Food & Drug Administration (FDA),Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,Patent & Trademark Office (PTO),SENATE,Treasury, Dept of,U.S. Trade Representative (USTR),White House Office   459139 0 0 2008-07-18T09:03:30-04:00
636654 BGR GOVERNMENT AFFAIRS 0b881c99-49be-4c59-9351-84a3c61d811f Q2 BGR GOVERNMENT AFFAIRS 5357 ADAMS RESPIRATORY THERAPEUTICS 2008 second_quarter PHA Monitoring and guidance with regard to FDA enforcement action, DXM-related litigation Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,SENATE 30000   0 0 2008-07-18T09:12:52-04:00
636726 US STRATEGIES f41615b6-684a-4b2f-bef5-56016fc43c03 Q2 US STRATEGIES 38825 NOVOLOGIX (FORMERLY ANCILLARY CARE MANAGEMENT) 2008 second_quarter PHA Medicare and Medicaid provisions relating to pharmacy and medication management policies HOUSE OF REPRESENTATIVES,SENATE 10000   0 0 2008-07-18T09:28:08-04:00
637592 BLUE CROSS AND BLUE SHIELD OF FLORIDA, INC. d5162114-cc85-49b7-bfd7-d6cb071f7e1d Q2 BLUE CROSS AND BLUE SHIELD OF FLORIDA, INC. 6382 BLUE CROSS AND BLUE SHIELD OF FLORIDA INC 2008 second_quarter PHA E-Prescribing; Effectiveness Research HOUSE OF REPRESENTATIVES,SENATE   340000 0 0 2008-07-18T11:12:05-04:00
637619 AMERICAN COLLEGE OF CLINICAL PHARMACY 4f03f83d-ed1f-4215-b734-08470e78242d Q2 AMERICAN COLLEGE OF CLINICAL PHARMACY 57258 AMERICAN COLLEGE OF CLINICAL PHARMACY 2008 second_quarter PHA Coverage for direct patient care services of qualified pharmacists under Medicare Part B. Agency for Healthcare Research & Quality (AHRQ),Centers For Medicare and Medicaid Services (CMS),Food & Drug Administration (FDA),Health Resources & Services Administration (HRSA),HOUSE OF REPRESENTATIVES,SENATE   55950 0 0 2008-07-18T11:14:40-04:00
637840 MARC ASSOCIATES, INC. 6662fbfe-e544-496a-9ad3-39def882b7eb Q2 MARC ASSOCIATES, INC. 23747 AMERICAN SOCIETY OF HEMATOLOGY 2008 second_quarter PHA Oncology drug issues. Centers For Disease Control & Prevention (CDC),Centers For Medicare and Medicaid Services (CMS),Food & Drug Administration (FDA),HOUSE OF REPRESENTATIVES,Natl Institutes of Health (NIH),SENATE 20000   0 0 2008-07-18T11:36:23-04:00
638242 THE OB-C GROUP, LLC 5689320d-6f6e-4c51-8a66-18a9f411c005 Q2 THE OB-C GROUP, LLC 29802 ELI LILLY 2008 second_quarter PHA HR 5629, Pathway for Biosimilars Act: biologics. S 1695, Biologics Price Competition and Innovation Act of 2007: biologics. HOUSE OF REPRESENTATIVES,SENATE 50000   0 0 2008-07-18T12:10:21-04:00
638540 VENABLE LLP 262178b5-3d11-4a04-b748-74026e1559aa Q2 VENABLE LLP 39941 ENDO PHARMACEUTICALS INC 2008 second_quarter PHA General issues affecting the pharmaceutical industry. HOUSE OF REPRESENTATIVES,SENATE     0 0 2008-07-18T12:58:27-04:00
638564 BLUE CROSS AND BLUE SHIELD ASSOCIATION 019d799d-cea9-4b6d-8187-64fc69da39b5 Q2 BLUE CROSS AND BLUE SHIELD ASSOCIATION 6358 BLUE CROSS AND BLUE SHIELD ASSOCIATION 2008 second_quarter PHA E-prescribing; Comparative Effectiveness Research: HR3162 "Children's Health and Medicare Protection Act of 2007" Section 904 only; HR2184 "Enhanced Health Care Value for All Act" Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,SENATE   2400000 0 0 2008-07-18T13:01:15-04:00

Next page

Advanced export

JSON shape: default, array, newline-delimited, object

CSV options:

CREATE TABLE lobbying_activities (
            id INTEGER PRIMARY KEY,
            filing_uuid TEXT NOT NULL,
            filing_type TEXT NOT NULL,
            registrant_name TEXT NOT NULL,
            registrant_id INTEGER,
            client_name TEXT NOT NULL,
            filing_year INTEGER NOT NULL,
            filing_period TEXT NOT NULL,
            issue_code TEXT,
            specific_issues TEXT,
            government_entities TEXT,
            income_amount INTEGER,
            expense_amount INTEGER,
            is_no_activity INTEGER DEFAULT 0,
            is_termination INTEGER DEFAULT 0,
            received_date TEXT,
            CONSTRAINT fk_activity_filing FOREIGN KEY (filing_uuid)
                REFERENCES lobbying_filings_raw(filing_uuid)
        );
CREATE INDEX idx_act_client_name ON lobbying_activities(client_name COLLATE NOCASE);
CREATE INDEX idx_act_issue_code ON lobbying_activities(issue_code);
CREATE INDEX idx_act_filing_year ON lobbying_activities(filing_year);
CREATE INDEX idx_act_filing_uuid ON lobbying_activities(filing_uuid);
Powered by Datasette · Queries took 2747.472ms · Data license: Public Domain (U.S. Government data) · Data source: Federal Register API & Regulations.gov API